GlassScriptPhysician profile
Cassidy Wikoff
NPI 1396824264
$2,618.57
in general payments reported to CMS, 2019-2025
19 companies · $34.53 in 2025
The $34.53 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $258 · 2022: $1,895 · 2023: $349 · 2024: $81.57 · 2025: $34.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,127.28 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $282.48 | 2021-2023 | Lifevest |
| Alnylam Pharmaceuticals INC. | $188.17 | 2021-2022 | |
| Abiomed | $177.02 | 2022-2023 | Impella |
| Merck Sharp & Dohme LLC | $154.44 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.70 | 2021-2022 | |
| Pfizer INC. | $94.47 | 2021-2022 | |
| Atricure, INC. | $91.15 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System, Synergy Ablation System |
| Novartis Pharmaceuticals Corporation | $86.02 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.26 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $59.90 | 2021-2022 | |
| United Therapeutics Corporation | $47.11 | 2021-2022 | |
| Silk Road Medical, INC. | $37.03 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Stryker Corporation | $27.31 | 2024 | Na |
| Takeda Pharmaceuticals U.S.A., INC. | $24.78 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $19.79 | 2023 | Teg6s Hemostasis System |
| Janssen Pharmaceuticals, INC | $15.17 | 2024 | Xarelto |
| Lilly USA, LLC | $12.70 | 2022 | |
| Philips North America LLC | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassidy Wikoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.